Data protection Impressum

R&D

In the heart of Fribourg, the Adolphe Merkle Institute (AMI) has grown into a globally recognized center of excellence in materials science. Founded in 2008 through the visionary endowment of Swiss entrepreneur Dr. Adolphe Merkle, the institute was built on a simple yet powerful belief: fundamental science can bridge the gap to real-world impact.

Why Switzerland

Adolphe Merkle Institute: Where science meets application in the heart of Fribourg

In an era increasingly defined by intelligent machines, researchers at EPFL are peering into the minds of AI models, and finding familiar patterns. In a discovery that blurs the boundaries between human cognition and artificial computation, they have identified specific units in large language models (LLMs) that mirror the brain’s language network.

EPFL researchers uncover “language neurons” in AI that echo the human brain

20 May 2025

In collaboration with MITdesignX, Institut Le Rosey is launching a new start-up acceleration program in Rolle, aiming to support early-stage ventures with global impact.

MITdesignX brings global accelerator to Le Rosey in Rolle

19 May 2025

Neuchâtel-based CCRAFT, a new spin-off from CSEM, has been officially launched as the world’s first production-ready foundry for Thin-Film Lithium Niobate (TFLN) photonic integrated circuits. The company aims to deliver millions of high-performance chips per year to support next-generation optical communication, quantum technologies, and advanced sensing.

CSEM spin-off CCRAFT launches world’s first industrial foundry for TFLN photonic chips

14 May 2025

Neuchâtel’s CSEM is playing a central role in the QUESTIONED project, an initiative aiming to reduce postoperative delirium (POD) in elderly patients through real-time brain activity monitoring during anesthesia.

CSEM technology supports breakthrough in EEG monitoring to reduce postoperative delirium

12 May 2025

HAYA Therapeutics, a precision medicine company based at Biopôle in Lausanne, has closed a USD 65 million Series A funding round to accelerate the clinical development of its RNA-guided therapies and expand its regulatory genome platform.

HAYA Therapeutics raises USD 65 million to advance RNA-guided therapies for chronic disease

12 May 2025

The latest edition of the Swiss Biotech Report underscores the continued growth and resilience of Switzerland’s biotech sector, attributing success to strong international collaborations and innovative advancements that promise to reshape healthcare worldwide.

The Swiss biotech industry: building resilience through global alliances

6 May 2025

University of Bern researchers develop ultrasound-powered method to clean stents non-invasively, improving patient care and reducing hospital costs.

University of Bern researchers pioneer ultrasound-based method to clean implanted medical devices

5 May 2025

From clinical research to international leadership, Incyte’s steady growth in Western Switzerland showcases the region’s strength in biopharmaceutical innovation.

Incyte, a key player in Western Switzerland’s biopharmaceutical innovation landscape

A collaborative research team from EPFL, the University of Geneva (UNIGE), and Geneva University Hospitals (HUG) has been awarded the 2025 Leenaards Science Prize for a pioneering project aimed at enhancing the effectiveness of immunotherapy by altering the mechanical properties of cancer cells.

Western Switzerland research teams explore new strategy to boost cancer immunotherapy

14 April 2025

1 2 3 4 5 … 14